Prevention of fetal loss in experimental antiphospholipid syndrome by in vivo administration of recombinant interleukin-3

The Journal of Clinical Investigation
P FishmanY Shoenfeld

Abstract

Antiphospholipid antibodies are strongly associated with arterial and venous thrombosis and with fetal loss. Recently an experimental model for antiphospholipid syndrome (APLS) was established in our laboratory. In this model, mice are immunized passively or actively with anticardiolipin antibodies and acquire the syndrome, which is characterized by prolonged activated partial thromboplastin time (APTT), thrombocytopenia, low fecundity rate, and fetal loss. In a normal process of pregnancy, lymphokines affect fetal implantation and development. Cytokines from the colony stimulating factor family, like GM-CSF and IL-3, were shown to be positive signals for implantation and to promote placental development and fetal growth. Given our preliminary findings of low IL-3 in mice with APLS and the efficacy of IL-3 in preventing fetal loss in a strain of mice prone to fetal resorption, our aim in the present study was to examine the effect of murine recombinant IL-3 (mrIL-3) on pregnant mice induced with experimental APLS. Mice were passively transfused to the tail vein, 24 h following mating, with anticardiolipin antibodies. The mice were divided into two groups: one group was injected intraperitoneally with mrIL-3 on days 6.5, 8.5, an...Continue Reading

References

Mar 1, 1991·Clinical Obstetrics and Gynecology·H L Brown
Apr 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·M BlankY Shoenfeld
Jul 1, 1990·Journal of Reproduction and Fertility·G ChaouatT G Wegmann
Apr 1, 1987·The Journal of Cell Biology·F BlasiK Danø
Dec 1, 1971·The Australian Journal of Experimental Biology and Medical Science·T R BradleyM A Sumner

❮ Previous
Next ❯

Citations

Nov 1, 1995·Journal of Clinical Immunology·D B Cines, K R McCrae
Jan 1, 1995·Clinical Reviews in Allergy & Immunology·J C PietteB Wechsler
Oct 21, 2009·Clinical Reviews in Allergy & Immunology·Ricard Cervera, Juan Balasch
Oct 10, 2001·Fertility and Sterility·L W ChamleyP M Johnson
Oct 19, 2002·Journal of Reproductive Immunology·L W Chamley
Apr 20, 2001·European Journal of Obstetrics, Gynecology, and Reproductive Biology·D VinatierJ L Houpeau
Jun 6, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Manjiri Khare, Catherine Nelson-Piercy
Apr 13, 1995·The New England Journal of Medicine·M D Lockshin
Mar 17, 2004·Current Opinion in Obstetrics & Gynecology·Howard J A Carp
Jun 17, 1999·Clinical Obstetrics and Gynecology·A L Clark
May 1, 1993·American Journal of Reproductive Immunology : AJRI·R Shurtz-SwirskiY Shoenfeld
Feb 1, 1996·American Journal of Reproductive Immunology : AJRI·P FishmanY Shoenfeld
Aug 1, 1997·American Journal of Reproductive Immunology : AJRI·M MaejimaY Taketani
Jul 13, 2002·Annals of the New York Academy of Sciences·Joab Chapman, Yehuda Shoenfeld
Jan 1, 1996·Annual Review of Medicine·S S Shapiro
Apr 1, 1993·The Journal of Clinical Investigation·M D Lockshin
Aug 29, 2013·Clinical & Developmental Immunology·T MarchettiP de Moerloose
May 16, 2001·Current Rheumatology Reports·L R Sammaritano
Mar 1, 2006·Rheumatic Diseases Clinics of North America·Doruk Erkan, Michael D Lockshin
Sep 12, 2006·Obstetrics and Gynecology Clinics of North America·Howard J A Carp
Mar 28, 2012·British Journal of Haematology·Sarah A BennettRoopen Arya
Mar 26, 2013·American Journal of Reproductive Immunology : AJRI·Joanne Kwak-KimAlice Gilman-Sachs
Oct 28, 2004·Thrombosis Research·Elizabeth M Benson
Jun 21, 2006·Seminars in Fetal & Neonatal Medicine·Kjersti M Aagaard-TilleryJess Dalton
Sep 6, 2001·Rheumatic Diseases Clinics of North America·H A ShehataM A Khamashta
Feb 1, 1997·Rheumatic Diseases Clinics of North America·A LynchW Emlen
Feb 1, 1997·Rheumatic Diseases Clinics of North America·L ZiporenY Shoenfeld
Jul 1, 1997·American Journal of Obstetrics and Gynecology·R M SilverD W Branch
Jan 1, 1998·Hematology·M H Mangi, A C Newland
Oct 26, 2016·Journal of Autoimmunity·Guillermo J Pons-EstelAngela Tincani
Apr 17, 2014·Scientific Reports·Natsuko KawanoAkihiro Umezawa
Aug 1, 1994·Lupus·M D Lockshin
Aug 1, 1994·Lupus·Y Shoenfeld, P Fishman
Oct 16, 2004·Lupus·G TrioloG Licata
Oct 16, 2004·Lupus·H Carp
Aug 2, 2003·Lupus·Y Shoenfeld

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antiphospholipid Syndrome

Antiphospholipid syndrome or antiphospholipid antibody syndrome (APS or APLS), is an autoimmune, hypercoagulable state caused by the presence of antibodies directed against phospholipids.